Terug
Dagbereik
€ 34,39
€ 34,39
52-Weeksbereik
€ 6,98
€ 34,39
Volume
21.644
50D / 200D Gem.
€ 13,01
/
€ 8,48
Vorige Slotkoers
€ 34,39
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -67,0 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | -72,2 | 3,9 |
| Rev Growth 5Y % | 32,9 | 10,0 |
| D/E | — | 0,2 |
Belangrijkste Punten
Revenue grew 32,91% annually over 5 years — strong growth
Generating 17,81M in free cash flow
PEG of 0,36 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 145,92%
Capital efficient — spends only 6,50% of revenue on capex
Groei
Revenue Growth (5Y)
32,91%
Revenue (1Y)178,83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-19,18%
Net Margin-72,19%
Op. Margin-42,44%
Veiligheid
Debt / Equity
N/A
Current Ratio2,70
Interest Coverage-2,13
Waardering
P/E Ratio
-66,97
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 178,83% | Revenue Growth (3Y) | 60,26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 32,91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25,54M | Net Income (TTM) | -18,44M |
| ROE | N/A | ROA | -20,38% |
| Gross Margin | 100,00% | Operating Margin | -42,44% |
| Net Margin | -72,19% | Free Cash Flow (TTM) | 17,81M |
| ROIC | -19,18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,70 |
| Interest Coverage | -2,13 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -66,97 | P/B Ratio | N/A |
| P/S Ratio | 48,34 | PEG Ratio | 0,36 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,23B | Enterprise Value | 1,23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,54M | 9,16M | 9,94M | 4,09M | 8,19M |
| Net Income | -18,44M | -25,04M | -32,01M | -24,81M | -19,02M |
| EPS (Diluted) | -0,63 | -0,88 | -1,27 | -1,00 | -0,86 |
| Gross Profit | 25,54M | 9,16M | 9,94M | 4,09M | 6,74M |
| Operating Income | -10,84M | -20,98M | -24,03M | -23,81M | -15,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90,45M | 36,95M | 29,34M | 44,30M | 63,61M |
| Total Liabilities | 106,82M | 77,77M | 71,63M | 57,67M | 54,69M |
| Shareholders' Equity | -16,37M | -40,82M | -42,29M | -13,37M | 8,92M |
| Total Debt | 58,76M | 58,96M | 57,71M | 47,49M | 43,35M |
| Cash & Equivalents | 59,04M | 19,46M | 6,47M | 24,62M | 47,10M |
| Current Assets | 80,62M | 27,26M | 19,57M | 34,07M | 56,33M |
| Current Liabilities | 29,87M | 16,47M | 57,03M | 38,24M | 13,60M |